Literature DB >> 9874214

Membrane topology of the myelin/oligodendrocyte glycoprotein.

B della Gaspera1, D Pham-Dinh, G Roussel, J L Nussbaum, A Dautigny.   

Abstract

Myelin/oligodendrocyte glycoprotein (MOG), a specific component of the mammalian central nervous system, is located on the surface of the oligodendrocyte plasma membrane and the outermost lamellae of mature myelin; it is expressed during the latter steps of myelinogenesis. It has been shown that MOG may play a pathological role in autoimmune demyelinating diseases of the central nervous system, although its physiological function remains unknown. MOG is an integral membrane glycoprotein with an extracellular immunoglobulin-like domain and two hydrophobic segments which were predicted to be membrane-spanning on the basis of hydropathy analysis. As a first step in elucidation of MOG function, we have investigated its membrane topology, combining immunofluorescence studies on cultured oligodendrocytes and MOG-transfected Chinese hamster ovary cells with biochemical analyses, including in vitro translation, membrane insertion and protease-digestion assays. Our results indicate that the C-terminal tail of MOG is located into the cytoplasm, and that only the first hydrophobic region of MOG spans the membrane whereas the second hydrophobic region appears to be semi-embedded in the lipid bilayer, lying partially buried in the membrane with its N-terminal and C-terminal boundaries facing the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874214     DOI: 10.1046/j.1432-1327.1998.2580478.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

Review 2.  Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice.

Authors:  Amanda Marchionatti; Mark Woodhall; Patrick Joseph Waters; Douglas Kazutoshi Sato
Journal:  Neurol Sci       Date:  2020-10-15       Impact factor: 3.307

Review 3.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

4.  Evolutionary and polymorphism analyses reveal the central role of BTN3A2 in the concerted evolution of the BTN3 gene family.

Authors:  Hassnae Afrache; Pierre Pontarotti; Laurent Abi-Rached; Daniel Olive
Journal:  Immunogenetics       Date:  2017-04-05       Impact factor: 2.846

5.  Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.

Authors:  Cécile Delarasse; Philippe Daubas; Lennart T Mars; Csaba Vizler; Tobias Litzenburger; Antonio Iglesias; Jan Bauer; Bruno Della Gaspera; Anna Schubart; Laurence Decker; Dalia Dimitri; Guy Roussel; Andrée Dierich; Sandra Amor; Andre Dautigny; Roland Liblau; Danielle Pham-Dinh
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

6.  Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Authors:  Patrice H Lalive; Til Menge; Cecile Delarasse; Bruno Della Gaspera; Danielle Pham-Dinh; Pablo Villoslada; H-C von Büdingen; Claude P Genain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

7.  Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.

Authors:  H-Christian von Büdingen; Til Menge; Stephen L Hauser; Claude P Genain
Journal:  Immunogenetics       Date:  2006-03-10       Impact factor: 2.846

Review 8.  The primate autoimmune encephalomyelitis model; a bridge between mouse and man.

Authors:  Bert A 't Hart; Yvette van Kooyk; Jeroen J G Geurts; Bruno Gran
Journal:  Ann Clin Transl Neurol       Date:  2015-03-18       Impact factor: 4.511

9.  Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.

Authors:  Aparna Shetty; Sheena G Gupta; Michel Varrin-Doyer; Martin S Weber; Thomas Prod'homme; Nicolas Molnarfi; Niannian Ji; Patricia A Nelson; Juan C Patarroyo; Ulf Schulze-Topphoff; Stephen E Fogal; Thomas Forsthuber; Raymond A Sobel; Claude C A Bernard; Anthony J Slavin; Scott S Zamvil
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-08-14

10.  Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport.

Authors:  Louise H Boyle; James A Traherne; Gemma Plotnek; Rosemary Ward; John Trowsdale
Journal:  J Neurochem       Date:  2007-06-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.